AREV Life Sciences Global Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CAD 0.008627 million compared to CAD 0.04259 million a year ago. Net loss was CAD 0.510094 million compared to CAD 0.566463 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.03 a year ago.